The recent global outbreak of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reminds us of the constant need for continued vaccine development as viral threats evolve.
Sartorius supports and enables scientists in their development of the next generation immuno-therapies, by providing solutions to streamline the workflows, increase speed and throughput, decrease cost.
This webcast will cover key products and Sartorius’ solutions used to address challenges at every stage of the process by:
Providing deeper biological Insight with Incucyte® Live-Cell Analysis Platform
Finding and characterizing best performing hits in shortest time with the iQue3® Advanced Flow Cytometry Platform
Rapid and real-time measurements of binding kinetics and affinity determination to rank vaccine and therapeutic candidates and efficient epitope binning for the selection of antibody clones with the Octet® BLI Platform
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.